Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low. If you miss any scheduled session you should contact your doctor immediately and fix an appointment as recommended by your doctor.
Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Dexamethasone (moderate)
Atazanavir (severe)
Erythromycin (moderate)
Itraconazole (severe)
Clozapine (severe)
Linezolid (moderate)
Clarithromycin (severe)
Atorvastatin (moderate)
Phenobarbital (moderate)
This medicine is used in the treatment of cancer that develops in the breast cells.
The medicine is used in the treatment of Kaposi's Sarcoma, a type of cancer that affects the cells that line the blood and lymph vessels.
The medicine is used for the treatment of testicular cancer, which affects the male sex organ (testicles).
This medicine is used in the treatment of Mycosis fungoides, the most common type of blood cancer (cutaneous t-cell lymphoma) which is characterized by rash, skin lesions, itchy skin, etc.
This medicine is used in the treatment of choriocarcinoma, a type of cancer that affects the uterus.
This medicine is used in the treatment of lymphoma, a type of cancer that affects the lymphocytes (infection-fighting cells of the immune system).
This medicine is used in the treatment of histiocytosis X, characterized by an abnormal increase in the number of specialized white blood cells called histiocytes (L-group).
The medicine is used for the treatment of Hodgkin's Disease, which is one of a group of cancers that develop in the lymphatic system (lymphoma).
Blood in urine and stools
Injection site pain and warmth
Fever and chills
Unusual bleeding or bruising
Joint pain
Swelling of feet or lower legs
Dizziness (rare)
This medicine is not recommended for use in patients with a known allergy to VELBE 10mg Injection Vial or any other inactive ingredients present in the formulation.
This medicine is not recommended for use in patients with an active bacterial infection due to the increased risk of worsening of the patient's condition.
This medicine is not recommended for use in patients who are suffering from myelosuppression due to the increased risk of worsening of the patient's condition.